News Bliss GVS Pharma Limited

Equities

BLISSGVS

INE416D01022

Market Closed - Bombay S.E. Other stock markets 03:30:52 26/06/2024 pm IST			5-day change	1st Jan Change
102.8 ^INR	-0.72%		-0.77%	-17.50%

20/06	Crisil Keeps BBB+ Rating on Bliss GVS Pharma's Bank Loans; Outlook Stable	MT
02/05	Bliss GVS Pharma Limited Reports Earnings Results for the Full Year Ended March 31, 2024	CI

Summary

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Crisil Keeps BBB+ Rating on Bliss GVS Pharma's Bank Loans; Outlook Stable	20/06	MT
Bliss GVS Pharma Limited Reports Earnings Results for the Full Year Ended March 31, 2024	02/05	CI
Bliss GVS Pharma Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	02/05	CI
Bliss GVS Pharma Limited Recommends Final Dividend for the Financial Year Ended March 31, 2024	02/05	CI
Bliss GVS Pharma Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	23/01	CI
Bliss GVS Pharma Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	01/11	CI
Assistant Commission of State Tax Maharashtra, Mumbai Initiates Search At Certain Premises of Bliss GVS Pharma Limited	07/23/07	CI
Bliss Gvs Pharma Limited Announces Change in the Designation of Mr. Vishal Vijay Rao	01/23/01	CI
Bliss GVS Pharma Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	01/23/01	CI
Bliss GVS Pharma Limited Declares Final Dividend for the Financial Year Ended March 31, 2023	19/23/19	CI
Ex-dividend day for final dividend	12/23/12	FA
Bliss GVS Pharma Gets Establishment Inspection Report from US FDA for Palghar, India Unit	15/23/15	MT
Bliss Gvs Pharma Limited Recommends Final Dividend for the Financial Year Ended March 31, 2023	11/23/11	CI
Bliss GVS Pharma Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023	11/23/11	CI
Bliss GVS Pharma Limited Reports Earnings Results for the Full Year Ended March 31, 2023	11/23/11	CI
Infomerics Keeps BBB Rating on Bliss GVS Pharma's Bank Financing; Outlook Stable	10/23/10	MT
Bliss GVS Pharma Gets Three Observations from US FDA's Plant Inspection in Maharashtra, India	20/23/20	MT
Bliss GVS Pharma Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	24/23/24	CI
Bliss GVS Pharma Names New CFO	30/22/30	MT
Bliss GVS Pharma Limited Appoints Mr. Deepak Sawant as Chief Financial Officer	30/22/30	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Bliss GVS Pharma Limited

Equities

BLISSGVS

INE416D01022

Summary

Filters